Citation Impact
Citing Papers
Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
2009
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Regulatory mechanisms of microRNA expression
2016
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
2016
Microbiota in health and diseases
2022 Standout
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
2020 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
MicroRNA regulation by RNA-binding proteins and its implications for cancer
2011
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations
2016
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
EMT: 2016
2016 Standout
Ki67 expression in breast cancer
2016 Standout
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
2014
Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells
2016
MicroRNA
2017 Standout
Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
2015
The Impact of microRNAs in Breast Cancer Angiogenesis and Progression
2018
Breast Cancer Treatment
2019 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory
2014
Noncanonical Activation of β-Catenin by Porphyromonas gingivalis
2015
Wnt/β-Catenin Signaling in Oral Carcinogenesis
2020
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Sandra Stein being referenced
Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer
2012
Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome
2006
Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events
2012
Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformation
2012
Bright-field In Situ Hybridization for HER2 Gene Amplification in Breast Cancer Using Tissue Microarrays
2009
Circulating Cell-Free Tumour DNA in the Management of Cancer
2015
Posttranscriptional Regulation of the Breast Cancer Susceptibility Gene BRCA1 by the RNA Binding Protein HuR
2008